Education

Ph.D., Division of Molecular Biology, Netherlands Cancer Institute, Amsterdam, the Netherlands, 2006

Current position

Tenure Track Junior PI at European Institute for the Biology of Aging (ERIBA), University Medical Center Groningen, University of Groningen, the Netherlands (since 12/2011)

Publications

1. Foijer, F.^#, DiTommaso, T., Donati, G., Hautaviita, K., Xie, S. Z., Heath, E., Smyth, I., Watt, F. M., Sorger, P. K. and Bradley, A. (2013). Spindle checkpoint deficiency is tolerated by murine epidermal cells but not hair follicle stem cells. Proc Natl Acad Sci U S A 110(8): 2928-2933.
   
2. Foijer, F.^# (2012). Mouse Models for Chromosomal Instability. In: Storchova, Z. (ed.). Aneuploidy in Health and Disease.  ISBN 979-953-307-449-7.
   
3. Orth, J. D., Kohler, R. H., Foijer, F., Sorger, P. K., Weissleder, R. and Mitchison, T. J.^# (2011). Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics. Cancer Res 71(13): 4608-4616.
   
4. Foijer, F.^# (2010). CINister thoughts. Biochem Soc Trans 38(6): 1715-1721.
   
5. van Harn, T.*, Foijer, F.*, van Vugt, M., Banerjee, R., Yang, F., Oostra, A., Joenje, H. and te Riele, H.^# (2010). Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev 24(13): 1377-1388.
   
6. Vormer, T. L., Foijer, F., Wielders, C. L. and te Riele, H. (2008). Anchorage-independent growth of pocket protein-deficient murine fibroblasts requires bypass of G2 arrest and can be accomplished by expression of TBX2. Mol Cell Biol 28(24): 7263-7273.
   
7. Foijer, F., Draviam, V. M. and Sorger, P. K.^# (2008). Studying chromosome instability in the mouse. Biochim Biophys Acta 1786(1): 73-82.
   
8. Foijer, F., Simonis, M., van Vliet, M., Wessels, L., Kerkhoven, R., Sorger, P. K. and Te Riele, H.^# (2008). Oncogenic pathways impinging on the G2-restriction point. Oncogene 27(8): 1142-1154.
   
9. Foijer, F.^# (2007). Celcyclus checkpoints en Cyclines. Tijdschrift Kanker [Dutch]
   
10. Foijer, F., Delzenne-Goette, E., Dekker, M. and Te Riele, H.^# (2007). In vivo significance of the G2 restriction point. Cancer Res 67(19): 9244-9247.
    
11. Foijer, F. and Te Riele, H.^# (2006). Restriction beyond the restriction point: mitogen requirement for G2 passage. Cell Div 1: 8.
    
12. Foijer, F. and te Riele, H.^# (2006). Check, double check: the G2 barrier to cancer. Cell Cycle 5(8): 831-836.
    
13. Foijer, F., Wolthuis, R. M., Doodeman, V., Medema, R. H. and te Riele, H.^# (2005). Mitogen requirement for cell cycle progression in the absence of pocket protein activity. Cancer Cell 8(6): 455-466.
    
14. Verlinden, L., Eelen, G., Beullens, I., Van Camp, M., Van Hummelen, P., Engelen, K., Van Hellemont, R., Marchal, K., De Moor, B., Foijer, F., Te Riele, H., Beullens, M., Bollen, M., Mathieu, C., Bouillon, R. and Verstuyf, A.^# (2005). Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3. J Biol Chem 280(45): 37319-37330.
    *Equal contributions
    ^#Corresponding author